Company Analysis

ARS Pharmaceuticals, Inc. (SPRY)

Nasdaq: SPRY · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2016
Grade5.0
◀ Past 5.7● Present 5.4▶ Future 3.8
1 est.

Who runs ARS Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Casale Donn
President and CEO. First filing Jun 2026, latest Oct 5, 2026, 0 filings in all.
Officers reporting now
11
of 23 people with a filing in the last fifteen months
Directors reporting now
12
44 people on the record since 2020
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Slebir John LChief Legal OfficerNov 2026Nov 4, 2026none
Casale DonnPresident and CEOJun 2026Oct 5, 2026none
Smith Margaret EkinsChief Commercial OfficerAug 2026Sep 2, 2026none
Shawver LauraChief Executive OfficerDec 2020Jun 26, 2026none
Fitzpatrick Alexander AChief Legal OfficerDec 2022Jun 12, 20261 · $0.00
Karas EricChief Commercial OfficerNov 2022Jun 12, 20261 · $300,000
Lowenthal Richard EPRESIDENT AND CEONov 2022Jan 5, 2026none
Scott Kathleen D.Chief Financial OfficerNov 2022Jan 5, 2026none
Dorsey BrianChief Operating OfficerDec 2022Jan 5, 20261 · $200,000
Chakma JustinChief Business OfficerNov 2022Jan 5, 20262 · $1.5M
Tanimoto SarinaCHIEF MEDICAL OFFICERNov 2022Jan 5, 2026none
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameRoleFirst filingLatest filingSales, 12 months
Dadoo RajeevdirectorNov 2022Jun 26, 2026none
Islam SaqibdirectorDec 2020Jun 26, 2026none
Kelly MichaeldirectorNov 2022Jun 26, 2026none
Kolchinsky PeterdirectorNov 2022Jun 26, 2026none
Ra Capital Healthcare Fund LPdirectorNov 2022Jun 26, 2026none
Ra Capital Management, L.P.directorNov 2022Jun 26, 2026none
Ra Capital Nexus Fund II, L.P.directorNov 2022Jun 26, 2026none
Saunders Brent LdirectorNov 2022Jun 26, 2026none
Schneider Phillip MdirectorNov 2022Jun 26, 2026none
Shah PratikdirectorNov 2022Jun 26, 2026none
Shah Rajeev M.directorNov 2022Jun 26, 2026none
Thompson Peter A.directorDec 2020Jun 26, 2026none
Earlier names on the record27, newest filing first
Deerfield Management Company, L.P. (Series C) · director · last filing Jul 2025Deerfield Mgmt III, L.P. · director · last filing Jul 2025Deerfield Mgmt IV, L.P. · director · last filing Jul 2025Deerfield Private Design Fund III, L.P. · director · last filing Jul 2025Deerfield Private Design Fund IV, L.P. · director · last filing Jul 2025Flynn James E · director · last filing Jul 2025Orbimed Advisors LLC · director · last filing Aug 2024Orbimed Capital Gp Vi LLC · director · last filing Aug 2024Orbimed Capital LLC · director · last filing Aug 2024Pratik Shah Living Trust Dated June 15, 2011 · 10% owner · last filing Jun 2024Leff Jonathan S · director · last filing Nov 2022Pepe Jeffrey C. · officer · last filing Sep 2022Capps Vickie L · director · last filing Jun 2022Hershberg Robert · director · last filing Jun 2022Koehler Maria · director · last filing Jun 2022Powell Andrew Kenneth William · director · last filing Jun 2022Root Jonathan D · director · last filing Jun 2022Hawkinson Russ · officer · last filing May 2022Odegard Valerie · officer · last filing May 2022Piazza Jonathan · officer · last filing May 2022Hunder Naomi · officer · last filing May 2022Schroeder Thilo · director · last filing Dec 2020Alexandria Venture Investments, LLC · 10% owner · last filing Dec 2020Presidio Management Group Xii, L.L.C. · 10% owner · last filing Dec 2020Tansey Casey M · 10% owner · last filing Dec 2020U.S. Venture Partners Xii-A, L.P. · 10% owner · last filing Dec 2020U.S. Venture Partners Xii, L.P. · 10% owner · last filing Dec 2020

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SPRY · research, not advice